Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |